Skip to main content

Branded

  • Study finds widespread nonadherence among schizophrenia patients

    NEW YORK — Nearly half of patients with schizophrenia don't comply with doctors' prescription instructions, according to a new physician survey.

  • AstraZeneca buys Spirogen for up to $440 million

    LONDON — AstraZeneca has acquired a British developer of biotech drugs for treating cancer, AstraZeneca said Tuesday.

    The company said its MedImmune subsidiary had acquired privately held Spirogen and also entered into a collaboration with ADC Therapeutics to develop two of ADC's antibody-drug conjugate programs, currently in pre-clinical development. MedImmune will make an equity investment in ADC, which has an existing licensing agreement with Spirogen.

  • Mark McClellan joins J&J board

    NEW BRUNSWICK, N.J. — Johnson & Johnson on Monday announced that Mark McClellan, senior fellow in economic studies and director of the Initiative on Value and Innovation in Health Care at the Brookings Institution, will join the company's board of directors on Oct. 15. McClellan will serve on the regulatory, compliance and government affairs committee, as well as the science, technology and sustainability committee.

  • Fewer than one-quarter of Medicare beneficiaries compared drug costs in 2013, missing $600 in savings

    MOUNTAIN VIEW, Calif. — More than three-quarters of Medicare beneficiaries don't compare drug prices when shopping for their health plans, according to a new study.

    The study, conducted by eHealth, found that 78% of respondents don't compare prices, but that the average beneficiary could have saved more than $600 this year on out-of-pocket prescription drug costs if he had. The study was based on an analysis of more than 450,000 unique visitor sessions during Medicare's 2013 Annual Enrollment Period.

  • NCPA names Merck 2013 Corporate Recognition Award recipient

    ORLANDO, Fla. — The National Community Pharmacists Association on Sunday recognized Merck with its 2013 Corporate Recognition Award — the award recognizes a company for its support and work on behalf of independent community pharmacies — during NCPA’s 115th Annual Convention and Trade Exposition.

  • Calif. bill to restrict biosimilars gets governor's veto

    NEW YORK — The governor of California has vetoed a bill that critics said would have limited patients' access to knock-off versions of biotech drugs.

  • FDA approves easy-to-use injectable methotrexate for RA, psoriasis, juvenile arthritis

    EWING, N.J. — The Food and Drug Administration has approved a new drug made by Antares Pharma for treating rheumatoid arthritis and psoriasis, the drug maker said Monday.

  • U.S. to command more than 90% of opioid-induced constipation market by 2017

    LONDON — The global market for drugs to treat constipation resulting from use of opioid painkillers will increase more than tenfold by 2017, according to new research.

X
This ad will auto-close in 10 seconds